Efficacy, safety and mechanism of Honghua Xiaoyao Pill in the treatment of peri-menopausal syndrome: A study protocol for a randomized controlled trial

Background: Peri-menopausal syndrome (PMPS) has a high incidence rate and seriously affects the physical and mental health of women. Honghua Xiaoyao Pill (HHXYP) is a Chinese patent medicine, which has been reported to be used to treat PMPS. However, there is still a lack of randomized clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiao, Zhou, Lishan, Dong, Haoxu, Tian, Man, Liu, Shiqin, Xu, Xiaohu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773080/
https://www.ncbi.nlm.nih.gov/pubmed/36569324
http://dx.doi.org/10.3389/fphar.2022.1001228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773080/
https://www.ncbi.nlm.nih.gov/pubmed/36569324
http://dx.doi.org/10.3389/fphar.2022.1001228

Ejemplares similares